Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > December 20, 2023
Daily News
December 20, 2023
- Japan to Cut Drug Prices by 0.97% on Healthcare Cost Basis in FY2024
December 20, 2023
- Gist of FY2024 Drug Pricing Reform
December 20, 2023
- Chugai’s Corporate VC Arm to Go Live in 2024
December 20, 2023
- Daiichi Sankyo Launch 2 PIII Breast Cancer Trials for TROP2 ADC
December 20, 2023
- Xocova Rights Sub-Licensed to Juniper in Singapore: Shionogi
December 20, 2023
- Otsuka Bags European Commercial Rights to Ionis’ HAE Drug
December 20, 2023
- Ono, EVQLV Link Arms on AI-Powered Antibody Drug Development
December 20, 2023
- Sanofi Files High-Dose Quadrivalent Flu Vaccine in Japan
December 20, 2023
- Goal-Setting for 2024: Crushing It
December 20, 2023
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…